On April 12th, the Nanjing Yangtze River International Conference Center once again became the focal point of the industry as the 2024 Second Synthetic Biology Industry Conference & Exhibition (SBC2024) grandly opened. This event brought together a large gathering of professionals, featuring leading figures, to focus on the latest technologies and future trends in synthetic biology.
Vertexyn Bioworks Co., Ltd. specializes in the research, production, and sales of high-value bio-based raw materials, staying at the forefront of synthetic biology. The company was invited to participate in this conference. Dr. Xu Fuchao, the company's R&D Director and Deputy General Manager, attended the event and delivered an engaging presentation on "Biological Manufacturing of High-Value Amino Acid Derivatives," thoroughly analyzing the significant potential of synthetic biology in the production of high-value amino acid derivatives.
Dr. Xu's presentation was both cutting-edge and in-depth. It not only provided a comprehensive analysis of synthetic biology's potential in producing high-value amino acid derivatives but also detailed Vertexyn Bioworks' latest research achievements and practical experiences in this field. He emphasized that synthetic biology technologies enable more efficient and environmentally friendly production of high-value amino acid derivatives, offering innovative raw materials and solutions for industries such as pharmaceuticals, chemicals, and food, thus driving the transformation and upgrading of the entire industry.
Additionally, Dr. Xu used a series of specific cases to elucidate the core concept of developing "new quality productive forces" at Vertexyn Bioworks. These cases not only showcased the company's strong capabilities and outstanding achievements in synthetic biology but also highlighted its firm commitment and relentless pursuit of advancing the industry.
At the conference, Vertexyn Bioworks actively engaged in in-depth exchanges and collaborative discussions with industry peers. By working closely with major enterprises and research institutions, the company aims to further drive innovation and application of synthetic biology technologies, injecting new vitality into the industry's development.
Looking Ahead
The successful hosting of the expo not only provided Vertexyn Bioworks with an excellent platform to showcase its strengths but also created a high-end platform for in-depth exchanges and collaborative development with top experts and representatives in the industry. In the future, Vertexyn Bioworks will continue to uphold the principles of innovation, collaboration, and mutual benefit, increasing its R&D investment, and advancing continuous innovation and application of synthetic biology technologies. The company is committed to contributing more wisdom and strength to sustainable development and writing a brilliant chapter in the field of synthetic biology.
Please follow
English
